aplastic anemia | Aplastic Anemia and MDS International Foundation

aplastic anemia

Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis

Author(s): 
Pagliuca S, Risitano AM, De Fontbrune FS, Robin M, Iori AP, Marotta S, Michonneau D, Villate A, Desmier D, Socié G, De Latour RP
Primary Author: 
Pagliuca S
Journal Title: 
Bone Marrow Transplant
Original Publication Date: 
Nov 2017

No abstract available.

Bone Marrow Diseases: 

Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia

Author(s): 
Lew JL, Fenderson JL, Carmichael MG
Primary Author: 
Lew JL
Journal Title: 
Hawaii J Med Public Health
Original Publication Date: 
Nov 2017

Hypoplastic Myelodysplastic Syndrome (h-MDS) comprises 15% of all MDS and has traditionally been difficult to distinguish from

Bone Marrow Diseases: 

Orlando

Thank you for attending the 2017 Patient and Family Conference in Orlando, FL.

Thank you for attending the 2017 Patient and Family Conference in Orlando, FL.
Event Date: 
Sat, 11/04/2017 -
8:00am to 3:30pm
Conference Event Type: 

Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

Author(s): 
Zhao X, Feng X, Wu Z, Winkler T, Desmond R, Olnes M, Dumitriu B, Townsley DM, Dunbar CE, Young NS
Primary Author: 
Zhao X
Journal Title: 
Exp Hematol
Original Publication Date: 
Sep 2017

Although hematopoietic growth factors are found at high levels in

Bone Marrow Diseases: 

Somatic HLA mutations expose the role of class I–mediated autoimmunity in aplastic anemia and its clonal complications

Author(s): 
Daria V. Babushok, Jamie L. Duke, Hongbo M. Xie, Natasha Stanley, Jamie Atienza, Nieves Perdigones, Peter Nicholas, Deborah Ferriola, Yimei Li, Hugh Huang, Wenda Ye, Jennifer J. D. Morrissette, Jane Kearns, David L. Porter, Gregory M. Podsakoff
Primary Author: 
Daria V. Babushok
Journal Title: 
Blood Advances
Original Publication Date: 
Oct 2017

Acquired

Bone Marrow Diseases: 

As Patient Advocate, Emma Makes New Friends

Person's Name: 
Emma

When Emma was still being seen at the NIH twice a week, we were talking with her physician’s assistant about her t-shirt fundraiser and her Facebook group. After hearing what Emma was doing with these activities, they asked her to be their new pediatric patient advocate, helping newer pediatric patients with advice on how to cope with treatments. This seemed to be another way we could help.

Bone Marrow Diseases: